Novacyt: Coronavirus Test Update
Following the completion of Public Health England’s formal evaluation of Primerdesign’s COVID-19 test, announced March 12, 2020, the government agency has commenced ordering the test.
Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine & Tobacco 2020
The company recently presented positive data from its multicenter study evaluating the Company’s proprietary deep transcranial magnetic stimulation (Deep TMS) system as an aid in smoking cessation in an oral presentation at the Society for Research on Nicotine & Tobacco (SRNT) annual conference, which takes place March 11-14, 2020, in New Orleans, Louisiana.
Jupiter Medical Center Adjusts Visitor Policy, Elective Procedures
Jupiter Medical Center advises visitors will be screened for potential exposure, travel history and upper respiratory tract symptoms. This new policy went into effect on Wednesday, March 18, and will remain in place until further notice.
Agilex Biolabs Announces 30% Labs Expansion and Offers Virtual Lab Tours During COVID-19 Outbreak
As the only FDA-inspected lab of its type in the region, Agilex Biolabs is located in Adelaide, South Australia, in a science and biotech specialist hub. The company specializes in bioanalysis for small molecules and biologics for PK, immunogenicity, and biomarkers utilizing the two platforms of LC-MS/MS and Immunoassay (MesoScale, Gyrolab).
COVID-19 Update: FDA Gives Flexibility to NYS Department of Health, FDA issues Emergency Use Authorization Diagnostic Testing
Yesterday, the U.S. Food and Drug Administration took two significant actions in the agency's ongoing and aggressive commitment to address the coronavirus outbreak COVID19.